Newcastle Disease Vaccine Market By Vaccine Type (Live Attenuated, Inactivated, Thermostable), By Species (Chicken, Duck, Goose and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 06-Jan-2021 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-5627 Status : Published

The Newcastle Disease Vaccine market is set for a rapid growth over the forecast period. In terms of revenue, the global Newcastle Disease Vaccine market accounted for USD 282.24 Million in 2019 and is expected to reach USD 389.82 Million by 2026, growing at a CAGR of 4.72%.

Description

The Newcastle Disease Vaccine market is set for a rapid growth over the forecast period. In terms of revenue, the global Newcastle Disease Vaccine market accounted for USD 282.24 Million in 2019 and is expected to reach USD 389.82 Million by 2026, growing at a CAGR of 4.72%.

Global Newcastle Disease Vaccine Market: Overview

Newcastle disease is an infectious disease of viral birds that affects many avian species, both domestic and wild; it is transmissible to humans. There are several Newcastle disease vaccines available on the market that are suitable for commercial chickens. The I-2 Newcastle disease vaccine (Thermostable Vaccine) has been produced for the local or regional development and to combat Newcastle disease in village chicken. After storage for one to two hours at room temperature, several Newcastle disease vaccinations worsen. This renders them unfit for use in villages where the vaccine will need to be transported at room temperature for hours or, in some cases, days. The I-2 vaccine also need long-term storage in the cold temperature, but the vaccine will not deteriorate as easily as conventional vaccines when the vaccine is delivered to the field.

Global Newcastle Disease Vaccine Market: Growth Factors

Raising vaccines to curb outbreaks of avian disease and increasing demand for food items linked to poultry are mainly driving the sector. In addition, the market is driven by growing awareness among veterinary practitioners of animal vaccination, increasing meat consumption, and rising government’s food safety initiatives. For example, according to the Middle East Rating Agency, the Qatar government established central food laboratories in April 2019 with various food safety procedures and analyses to ensure that the consumers are delivered with contamination-free, healthy, and high-quality meat products. The growing population of poultry is also driving the market demand for products. Consumption of contaminated meat threatens human health, making it imperative that birds are vaccinated prior to use. The rapid spread of illnesses and the lack of treatment options are the key challenges faced by poultry farms. Vaccination is necessary to avoid such situations. Compulsory vaccination of other domesticated and agricultural animals, increased inventories of poultry, improved productivity of livestock and an increased emphasis on food safety contribute significantly to market growth.

Global Newcastle Disease Vaccine Market: Segmentation

The global Newcastle Disease Vaccine market is segmented into vaccine type, species and region. By vaccine type, the market is segmented into live attenuated, inactivated, and thermostable. Of these thermostable is expected to grow at a fastest rate due to its resistance to inactivation when exposed to high temperatures. On the basis of species, the market is categorized into chicken, duck, goose and others. Among this, chicken module held the largest market share in 2019. Chickens are vulnerable to many diseases that are contagious. The viral disease known as Newcastle disease, which causes catastrophic losses of both commercial and village chickens, is one of the most significant of these. Reducing the loss of large numbers of village chickens to Newcastle's virulent disease is a significant first step in improving their productivity.

Global Newcastle Disease Vaccine Market: Regional Analysis

Due to increased consumption of poultry-related food items, consumer perception of food safety, and a high incidence of avian diseases, North America has dominated the global market and is expected to sustain its lead over the forecast period. In addition, the booming production of poultry meat has played a key role in the region's dominance. According to the United Nations Food and Agriculture Organization (UNFAO), the U.S. is the world's largest producer of poultry meat, accounting for 18.0 percent of total production. Furthermore, the adoption of poultry vaccines in the country is being driven by joint strategic projects and acquisitions to further foster better avian health. Market development is also being fueled by increased investment on animal welfare and favorable reimbursement policies.

The European market is expected to emerge as a strong contender because of government measures for research and development activities and rapid progress in animal husbandry practices. The Asia Pacific market is expected to report the fastest growth rate over the forecast period, due to growing awareness of poultry vaccines and the increase in the number of vaccination awareness programs in the region.

Global Newcastle Disease Vaccine Market: Competitive Players

Some of key players in Newcastle Disease Vaccine market are Merial, QYH Biotech, CEVA, Yebio, Ringpu (Tianjin) Bio-Pharmacy Co., Ltd, Harbin Veterinary Research Institute, Merck Animal Health, ChengDu Tecbond, DHN, Zoetis, Elanco (Lohmann), CAVAC, Vaksindo, FATRO and others.

Global Newcastle Disease Vaccine Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.2.Report Scope
  • Chapter 2.Research Methodulogy
    • 2.1.Research Methodulogy
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global Newcastle Disease Vaccine Market, 2016 – 2026 (USD Million)
    • 3.2.Global Newcastle Disease Vaccine Market: Snapshot
  • Chapter 4.Newcastle Disease Vaccine Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
    • 4.3.Market Restraints
    • 4.4.Market Opportunities
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global Newcastle Disease Vaccine Market Attractiveness, By Vaccine Type
    • 5.2.Global Newcastle Disease Vaccine Market Attractiveness, By Species
    • 5.3.Global Newcastle Disease Vaccine Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Company Market Share Analysis - 2019
      • 6.1.1.Global Newcastle Disease Vaccine Market: Company Market Share, 2019
    • 6.2.Strategic Developments
  • Chapter 7.Newcastle Disease Vaccine Market – Vaccine Type Segment Analysis
    • 7.1.Global Newcastle Disease Vaccine Market Overview: by Vaccine Type
      • 7.1.1.Global Newcastle Disease Vaccine Market Revenue Share, by Vaccine Type, 2019 & 2026
    • 7.2.Global Newcastle Disease Vaccine Market Analysis/Overview – By Vaccine Type
      • 7.2.1.Live Attenuated – Overview/Analysis
      • 7.2.2.Inactivated – Overview/Analysis
      • 7.2.3.Thermostable– Overview/Analysis
    • 7.3.Live Attenuated
      • 7.3.1.Global Newcastle Disease Vaccine Market for Live Attenuated, Revenue (USD Million) 2016 - 2026
    • 7.4.Inactivated
      • 7.4.1.Global Newcastle Disease Vaccine Market for Inactivated, Revenue (USD Million) 2016 – 2026
    • 7.5.Thermostable
      • 7.5.1.Global Newcastle Disease Vaccine Market for Thermostable, Revenue (USD Million) 2016 - 20267
  • Chapter 8.Newcastle Disease Vaccine Market – Species Segment Analysis
    • 8.1.Global Newcastle Disease Vaccine Market Overview: by Species
      • 8.1.1.Global Newcastle Disease Vaccine Market Revenue Share, by Species, 2019 & 2026
    • 8.2.Global Newcastle Disease Vaccine Market Analysis/Overview – By Species
      • 8.2.1.Chicken – Overview/Analysis
      • 8.2.2.Duck – Overview/Analysis
      • 8.2.3.Goose– Overview/Analysis
      • 8.2.4.Others – Overview/Analysis
    • 8.3.Chicken
      • 8.3.1.Global Newcastle Disease Vaccine Market for Chicken, Revenue (USD Million) 2016 - 2026
    • 8.4.Duck
      • 8.4.1.Global Newcastle Disease Vaccine Market for Duck, Revenue (USD Million) 2016 - 2026
    • 8.5.Goose
      • 8.5.1.Global Newcastle Disease Vaccine Market for Goose, Revenue (USD Million) 2016 – 2026
    • 8.6.Others
      • 8.6.1.Global Newcastle Disease Vaccine Market for Others, Revenue (USD Million) 2016 - 2026
  • Chapter 9.Newcastle Disease Vaccine Market – Regional Analysis
    • 9.1.Global Newcastle Disease Vaccine Market: Regional Overview
      • 9.1.1.Global Newcastle Disease Vaccine Market Revenue Share, by Region, 2019 & 2026
      • 9.1.2.Global Newcastle Disease Vaccine Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 9.2.North America
      • 9.2.1.North America Newcastle Disease Vaccine Market Revenue, 2016 - 2026 (USD Million)
      • 9.2.2.North America Newcastle Disease Vaccine Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.2.3.North America Newcastle Disease Vaccine Market Revenue, by Vaccine Type, 2016 – 2026
      • 9.2.4.North America Newcastle Disease Vaccine Market Revenue, by Species, 2016 – 2026
      • 9.2.5. U.S.
      • 9.2.6.Canada
    • 9.3.Europe
      • 9.3.1.Europe Newcastle Disease Vaccine Market Revenue, 2016 - 2026 (USD Million)
      • 9.3.2.Europe Newcastle Disease Vaccine Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.3.3.Europe Newcastle Disease Vaccine Market Revenue, by Vaccine Type, 2016 – 2026
      • 9.3.4.Europe Newcastle Disease Vaccine Market Revenue, by Species, 2016 – 2026
      • 9.3.5.Germany
      • 9.3.6.France
      • 9.3.7. U.K.
      • 9.3.8.Rest of Europe
    • 9.4.Asia Pacific
      • 9.4.1.Asia Pacific Newcastle Disease Vaccine Market Revenue, 2016 - 2026 (USD Million)
      • 9.4.2.Asia Pacific Newcastle Disease Vaccine Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.4.3.Asia Pacific Newcastle Disease Vaccine Market Revenue, by Vaccine Type, 2016 – 2026
      • 9.4.4.Asia Pacific Newcastle Disease Vaccine Market Revenue, by Species, 2016 – 2026
      • 9.4.5.China
      • 9.4.6.Japan
      • 9.4.7.India
      • 9.4.8.Rest of Asia Pacific
    • 9.5.Latin America
      • 9.5.1.Latin America Newcastle Disease Vaccine Market Revenue, 2016 - 2026 (USD Million)
      • 9.5.2.Latin America Newcastle Disease Vaccine Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.5.3.Latin America Newcastle Disease Vaccine Market Revenue, by Vaccine Type, 2016 – 2026
      • 9.5.4.Latin America Newcastle Disease Vaccine Market Revenue, by Species, 2016 – 2026
      • 9.5.5.Brazil
      • 9.5.6.Mexico
      • 9.5.7.Rest of Latin America
    • 9.6.The Middle-East and Africa
      • 9.6.1.The Middle-East and Africa Newcastle Disease Vaccine Market Revenue, 2016 - 2026 (USD Million)
      • 9.6.2.The Middle-East and Africa Newcastle Disease Vaccine Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.6.3.The Middle-East and Africa Newcastle Disease Vaccine Market Revenue, by Vaccine Type, 2016 – 2026
      • 9.6.4.The Middle-East and Africa Newcastle Disease Vaccine Market Revenue, by Species, 2016 – 2026
  • Chapter 10.Company Profiles
    • 10.1.Merial
    • 10.2.QYH Biotech
    • 10.3.CEVA
    • 10.4.Yebio
    • 10.5.Ringpu(Tianjin)Bio-Pharmacy Co., Ltd
    • 10.6.Harbin Veterinary Research Institute
    • 10.7.Merck Animal Health
    • 10,8 .ChengDu Tecbond
    • 10.9.DHN
    • 10.1.Zoetis
    • 10.11.Elanco (Lohmann)
    • 10.12.CAVAC
    • 10.13.Vaksindo
    • 10.14.FATRO
    • 10.21.Others

Methodology


Frequently Asked Questions

Raising vaccines to curb outbreaks of avian disease and increasing demand for food items linked to poultry are mainly driving the sector. In addition, the market is driven by growing awareness among veterinary practitioners of animal vaccination, increasing meat consumption, and rising government’s food safety initiatives. The growing population of poultry is also driving the market demand for products. Consumption of contaminated meat threatens human health, making it imperative that birds are vaccinated prior to use. The rapid spread of illnesses and the lack of treatment options are the key challenges faced by poultry farms. Vaccination is necessary to avoid such situations. Compulsory vaccination of other domesticated and agricultural animals, increased inventories of poultry, improved productivity of livestock and an increased emphasis on food safety contribute significantly to market growth.

According to Zion Market Research, the Newcastle Disease Vaccine market is expected to generate revenue of around USD 389.82 Million by the end of 2026, growing at a CAGR of 4.72%.

North America dominated the global market and is likely to retain its lead over the forecast period, owing to increase in consumption of poultry-related food products, consumer awareness concerning food safety, and high incidence of avian diseases. Moreover, soaring production of poultry meat has played a key role in the dominance of the region. According to the United Nation Food and Agriculture Organization (UNFAO), U.S. is the largest producer of poultry meat in the world, amounting to 18.0% of the overall output. Furthermore, the adoption of poultry vaccines in the country is being driven by joint strategic projects and acquisitions to further foster better avian health. Market development is also being fueled by increased investment on animal welfare and favorable reimbursement policies.

The European market is expected to emerge as a strong contender because of government measures for research and development activities and rapid progress in animal husbandry practices. The Asia Pacific market is expected to report the fastest growth rate over the forecast period, due to growing awareness of poultry vaccines and the increase in the number of vaccination awareness programs in the region.

Some of key players in Newcastle Disease Vaccine market are Merial, QYH Biotech, CEVA, Yebio, Ringpu (Tianjin) Bio-Pharmacy Co., Ltd, Harbin Veterinary Research Institute, Merck Animal Health, ChengDu Tecbond, DHN, Zoetis, Elanco (Lohmann), CAVAC, Vaksindo, FATRO and others.

 

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social